Sol-Gel Technologies (SLGL) Consolidated Net Income (2017 - 2026)

Sol-Gel Technologies' (SLGL) quarterly Consolidated Net Income came in at $3.9 million in Q1 2026, down 57.49% year-on-year from $9.1 million in Q1 2025, and up 106.23% on a QoQ basis from -$61.9 million in Q4 2025.

Sol-Gel Technologies (SLGL) Consolidated Net Income (2017 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has 10 years of Consolidated Net Income data on file, last reported at $3.9 million in Q1 2026.

  • On a quarterly basis, Consolidated Net Income fell 57.49% year-over-year to $3.9 million in Q1 2026; TTM through Mar 2026 was -$53.1 million, a 15.41% decrease from a year earlier, with the FY2025 full-year figure at -$66.0 million, down 6.86% from the prior year.
  • Consolidated Net Income for Q1 2026 stood at $3.9 million, up from -$61.9 million in the prior quarter.
  • Over the last five years, Consolidated Net Income for SLGL reached as high as $11.2 million in Q2 2025 and fell as low as -$61.9 million in Q4 2025.
  • Historically, Consolidated Net Income has averaged -$11.5 million across 5 years, with a median of -$828000.0 in 2024.
  • Across the five-year window, Consolidated Net Income slumped 1509.72% in 2023 and soared 591.5% in 2025, its largest moves.
  • Year by year, Consolidated Net Income stood at -$50.9 million in 2022, then slipped by 4.75% to -$53.3 million in 2023, then retreated by 4.82% to -$55.9 million in 2024, then decreased by 10.78% to -$61.9 million in 2025, then soared by 106.23% to $3.9 million in 2026.
  • Per Business Quant data, the three most recent Consolidated Net Income figures were $3.9 million in Q1 2026, -$61.9 million in Q4 2025, and -$6.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -37.09 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -14.46 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 227.36 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 727.20 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -26.94 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 498.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -453.82 Mn
10 Sol-Gel Technologies 234.04 Mn 223.91 Mn - 3.86 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.86 Mn
Dec 31, 2025 -61.92 Mn
Sep 30, 2025 -6.29 Mn
Jun 30, 2025 11.23 Mn
Mar 31, 2025 9.07 Mn
Dec 31, 2024 -55.89 Mn
Sep 30, 2024 -828,000.00
Jun 30, 2024 1.62 Mn
Mar 31, 2024 6.71 Mn
Dec 31, 2023 -53.32 Mn
Sep 30, 2023 -6.31 Mn
Jun 30, 2023 -6.53 Mn
Mar 31, 2023 11.06 Mn
Dec 31, 2022 -50.90 Mn
Sep 30, 2022 -3.63 Mn
Jun 30, 2022 463,000.00
Mar 31, 2022 5.95 Mn
Dec 31, 2021 13.55 Mn
Sep 30, 2021 1.27 Mn
Jun 30, 2021 8.04 Mn